How to Get a GLP-1 Prescription: The Complete Guide to Access Pathways

The three access pathways

Getting a GLP-1 prescription requires a licensed prescriber in the United States. There are three main routes:

1. Primary care physician (PCP) — your existing doctor or family practice
2. Specialist (endocrinologist, obesity medicine physician) — specialist care
3. Telehealth provider — online-only prescribing services

Each pathway has different timelines, costs, monitoring requirements, and suitability for different patients.

Pathway 1: Primary care physician

How it works: Request an appointment specifically to discuss GLP-1 therapy for weight management or diabetes management. Bring documentation of your weight history, any comorbidities (diabetes, high blood pressure, sleep apnoea, cardiovascular disease), and any prior weight loss attempts.

What your PCP will do:

• Review your BMI, medical history, and current medications
• Assess contraindications (personal/family history of MTC, pancreatitis history, etc.)
• If prescribing, submit a prior authorisation to your insurance (often required)
• Order baseline labs (HbA1c, metabolic panel, thyroid function if indicated)

Timeline: Initial appointment can be weeks to months depending on practice. Prior authorisation processing takes 1–4 weeks. Total time to first prescription: 1–8 weeks.

Cost: Standard office copay with insurance. Labs covered or low-cost with insurance.

Monitoring: Your PCP will typically schedule follow-up appointments quarterly or as needed. The level of ongoing monitoring varies significantly by practice.

When PCP is the best pathway:

• You already have a relationship with a PCP who is comfortable prescribing GLP-1 drugs
• You have existing comorbidities (T2D, cardiovascular disease) that your PCP manages
• Your insurance has prior authorisation requirements that require specialist prescribing documentation

Pathway 2: Endocrinologist or obesity medicine specialist

How it works: Endocrinologists specialise in hormone disorders including diabetes. Obesity medicine physicians specialise in weight management. Both are more likely to be experienced with GLP-1 therapy than a general PCP.

What to expect:

• More comprehensive metabolic assessment
• More detailed body composition, labs, and risk stratification
• Specialist-level monitoring of GLP-1 response and dose titration
• Sometimes required by insurance as a condition of prior authorisation

Timeline: Specialist appointments can have waiting lists of 1–6 months in many areas. Total time to first prescription may be 2–6 months through this route.

Cost: Higher office visit copay than PCP. May require referral from PCP depending on insurance.

When a specialist is the best pathway:

• Complex clinical picture: T1D off-label, eating disorder history, multiple comorbidities
• Insurance requires specialist involvement for prior authorisation
• Prior treatment failures or significant weight management history
• You want the highest level of clinical expertise

Pathway 3: Telehealth prescribers

How it works: GLP-1 telehealth has grown substantially since 2022. Services such as Hims, Ro Body, Henry Meds, Mochi Health, Found Health, Form Health, and others allow patients to complete an online intake, submit photos and documents, have a brief video or asynchronous consultation with a licensed prescriber, and receive a GLP-1 prescription — often within days.

The intake process typically includes:

• BMI confirmation (height and weight entry; sometimes photo of scale)
• Medical history questionnaire
• Contraindication screening
• ID verification
• Brief prescriber review (synchronous video or asynchronous chart review)

Timeline: Initial prescription in 24–72 hours for most telehealth services. Some offer same-day prescriptions.

Cost:

• Consultation fee: $0–$100 depending on service
• Monthly subscription (if applicable): $100–$200 for the telehealth service itself
• Drug cost: either branded (covered by your insurance + prescription sent to pharmacy) or compounded (supplied by the service's affiliated pharmacy at $150–$450/month)

What telehealth prescribers typically do not provide:

• Comprehensive baseline labs (some do; most do not require)
• In-person examination
• Ongoing specialist monitoring
• Insurance prior authorisation management (most telehealth services do not navigate insurance)

When telehealth is the best pathway:

• You meet the basic eligibility criteria (BMI ≥30 or ≥27 with comorbidity) and have no significant contraindications
• Speed and convenience are priorities
• You are primarily pursuing the cash-pay compounded route
• You do not have or want a PCP relationship for this purpose

What you need to qualify

GLP-1 drugs are approved for:

Obesity indication (Wegovy/Zepbound):

• BMI ≥30 (obese), OR
• BMI ≥27 (overweight) with at least one weight-related comorbidity: T2D, hypertension, dyslipidaemia, sleep apnoea, or cardiovascular disease

T2D indication (Ozempic/Mounjaro):

• Confirmed type 2 diabetes diagnosis
• Inadequate glycaemic control on existing therapy

Most prescribers — telehealth included — will not prescribe for BMI below 27 without documented medical justification. Prescribers who advertise GLP-1 for any patient regardless of BMI are operating outside standard-of-care guidelines. For the full eligibility breakdown, see GLP-1 eligibility criteria.

The insurance pathway: what to know before starting

If you want insurance to cover your GLP-1 prescription, route through your PCP or specialist — telehealth services typically do not manage insurance prior authorisations.

Steps for insurance coverage:

1. Confirm your plan covers GLP-1 obesity drugs (many still do not for weight management only; most cover for T2D)
2. Get an appointment with a prescriber who will manage the prior authorisation process
3. Document BMI, comorbidities, and prior weight loss attempts (insurers commonly require proof of prior failed interventions)
4. Submit prior authorisation (your prescriber does this)
5. Appeal if denied (first denial is frequently not the final answer — see our prior authorisation appeal guide)

Timeline: 4–12 weeks from first appointment to approved prior auth is typical.

If you are outside the US

GLP-1 access pathways differ significantly outside the US:

UK: Wegovy (semaglutide 2.4 mg) is available through specialist NHS Tier 3 weight management services and increasingly via private prescribing. NHS access remains limited by budget. Private prescribing through providers like Juniper Health is available at lower cost than US branded pricing.

EU: Access varies by country. Germany, France, and Scandinavia have the most developed access frameworks. Compounding is less widespread.

Canada: Ozempic is covered for T2D by most provincial formularies; Wegovy approval and coverage is expanding. Private prescription is available.

Summary

Getting a GLP-1 prescription involves three pathways: PCP (slow, insurance-friendly), specialist (slower, highest expertise), or telehealth (fast, cash-friendly). For patients meeting the BMI criteria (≥30, or ≥27 with comorbidity), telehealth is the fastest access route at 24–72 hours. For insurance coverage of branded drugs, PCP/specialist with prior authorisation management is required. For a ranked comparison of every access pathway by cost, see cheap GLP-1 alternatives. For the telehealth providers best suited to cash-pay patients, see best cash-pay GLP-1 telehealth.